The 340B Drug Pricing Program, designed to provide discounted medications to safety-net hospitals and clinics serving low-income populations, is at the center of a heated legal and legislative battle nationwide.
Drug manufacturers have imposed restrictions on contract pharmacies, limiting access to discounted medications.
Additionally, critics argue that predatory practices by pharmacy benefit managers have created further challenges.
Mick Pickos – chief pharmacy officer with Central Florida Health Care – described being sandwiched between drug manufacturers and benefit managers, which he says are creating obstacles that limit the program’s effectiveness.
Read more here